Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about Ideaya Biosciences aggregated by PharmaCompass.com.

    Client Virtual Booth

    IDEAYA BIOSCIENCES

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Ideaya Biosciences
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    7000 Shoreline Court, Suite 350 South San Francisco, CA 94080
    Telephone
    Telephone
    (650) 443-6209
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ideayabio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ideaya-biosciences
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    IDEAYA's Darovasertib Uveal Melanoma Data in ASCO Oral Session
    IDEAYA's Darovasertib Uveal Melanoma Data in ASCO Oral Session

    https://www.prnewswire.com/news-releases/ideaya-biosciences-announces-asco-2024-oral-presentation-for-darovasertib-in-neoadjuvant-uveal-melanoma-phase-2-investigator-sponsored-study-302125242.html

    PR NEWSWIRE
    24 Apr 2024
    Share Share
    IDEAYA Selects IDE397 MTAP-Del NSCLC Phase 2 Expansion Dose
    IDEAYA Selects IDE397 MTAP-Del NSCLC Phase 2 Expansion Dose

    https://www.prnewswire.com/news-releases/ideaya-biosciences-announces-selection-of-move-forward-phase-2-expansion-dose-for-ide397-monotherapy-in-mtap-deletion-squamous-non-small-cell-lung-cancer-302122601.html

    PR NEWSWIRE
    22 Apr 2024
    Share Share
    IDEAYA Announces Clinical Collaboration to Evaluate IDE161
    IDEAYA Announces Clinical Collaboration to Evaluate IDE161

    https://www.prnewswire.com/news-releases/ideaya-announces-clinical-collaboration-to-evaluate-ide161-in-combination-with-keytruda-pembrolizumab-in-patients-with-endometrial-cancer-302085972.html

    PR NEWSWIRE
    12 Mar 2024
    Share Share
    IDEAYA to Participate in Upcoming February 2024 Investor Relations Events
    IDEAYA to Participate in Upcoming February 2024 Investor Relations Events

    https://www.prnewswire.com/news-releases/ideaya-biosciences-to-participate-in-upcoming-february-2024-investor-relations-events-302049960.html

    PR NEWSWIRE
    01 Feb 2024
    Share Share
    IDEAYA Bio Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    IDEAYA Bio Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

    https://media.ideayabio.com/2024-01-26-IDEAYA-Biosciences-Announces-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4

    PRESS RELEASE
    26 Jan 2024
    Share Share
    IDEAYA Announces Participation at the 42nd Annual J.P. Morgan Conference
    IDEAYA Announces Participation at the 42nd Annual J.P. Morgan Conference

    https://media.ideayabio.com/2024-01-07-IDEAYA-Biosciences-Announces-Participation-at-the-42nd-Annual-J-P-Morgan-Healthcare-Conference-and-2024-Corporate-Guidance

    PRESS RELEASE
    07 Jan 2024
    Share Share
    IDEAYA Announces Agenda for Investor R&D Day Webcast on December 4, 2023
    IDEAYA Announces Agenda for Investor R&D Day Webcast on December 4, 2023

    https://www.prnewswire.com/news-releases/ideaya-announces-agenda-for-investor-rd-day-webcast-on-december-4-2023-302003703.html

    PR NEWSWIRE
    03 Dec 2023
    Share Share
    IDEAYA Biosciences, Inc. Reports Third Quarter 2023 Financial Results
    IDEAYA Biosciences, Inc. Reports Third Quarter 2023 Financial Results

    https://www.prnewswire.com/news-releases/ideaya-biosciences-inc-reports-third-quarter-2023-financial-results-and-provides-business-update-301979207.html

    PR NEWSWIRE
    07 Nov 2023
    Share Share
    IDEAYA Biosciences Announces Plans for Investor R&D Day
    IDEAYA Biosciences Announces Plans for Investor R&D Day

    https://www.prnewswire.com/news-releases/ideaya-biosciences-announces-plans-for-investor-rd-day-and-participation-in-jefferies-london-healthcare-conference-301973606.html

    PR NEWSWIRE
    01 Nov 2023
    Share Share
    IDEAYA Bio Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    IDEAYA Bio Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

    https://media.ideayabio.com/2023-10-27-IDEAYA-Biosciences-Announces-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4

    PRESS RELEASE
    27 Oct 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search